<DOC>
	<DOCNO>NCT00739960</DOCNO>
	<brief_summary>The purpose study determine safe effective Abatacept treat patient progressive pulmonary sarcoidosis .</brief_summary>
	<brief_title>Safety Study Abatacept Treat Refractory Sarcoidosis</brief_title>
	<detailed_description />
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Primary Diagnosis sarcoidosis least 1 year lung disease Active disease despite current treatment On stable dose sarcoidosis treatment oral steroid , methotrexate , hydroxychloroquine , least 90 day Primary Previous treatment Abatacept Currently receive receive within last 60 day follow : TNFÎ±inhibitors ( infliximab , etanercept , adalimumab ) Currently receive receive within last 30 day follow : cyclosporine , tacrolimus leflunomide Previous treatment IVIg within last 6 month History chronic infection active within last 60 day , herpes zoster within last 6 month , infection require hospitalization intravenous medication within last 60 day oral medication within last 2 week History congestive heart failure HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>